Similar articles

• Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.

  Westh H, Frimodt-Møller N, Gutschik E, Bangsborg J. Westh H, et al. APMIS. 1992 Sep;100(9):856-60. APMIS. 1992. PMID: 1389104
• Identification of Haemophilus haemolyticus in clinical samples and characterization of their mechanisms of antimicrobial resistance.

  Marti S, Puig C, de la Campa AG, Tirado-Velez JM, Tubau F, Domenech A, Calatayud L, Garcia-Somoza D, Ayats J, Liñares J, Ardanuy C. Marti S, et al. J Antimicrob Chemother. 2016 Jan;71(1):80-4. doi: 10.1093/jac/dkv307. Epub 2015 Oct 15. J Antimicrob Chemother. 2016. PMID: 26472767
• Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.

  Jones RN, Washington JA, Pfaller MA, Koontz FP, Gerlach EH, Erwin ME. Jones RN, et al. J Antimicrob Chemother. 1991 Mar;27(3):390-2. doi: 10.1093/jac/27.3.390. J Antimicrob Chemother. 1991. PMID: 2037544 No abstract available.
• Prevalence and mechanisms of β-lactam resistance in Haemophilus haemolyticus.

  Witherden EA, Tristram SG. Witherden EA, et al. J Antimicrob Chemother. 2013 May;68(5):1049-53. doi: 10.1093/jac/dks532. Epub 2013 Jan 11. J Antimicrob Chemother. 2013. PMID: 23315478
• Haemophilus infections in humans.

  Mihancea N. Mihancea N. Roum Arch Microbiol Immunol. 1993 Jan-Mar;52(1):5-13. Roum Arch Microbiol Immunol. 1993. PMID: 8173124 Review. No abstract available.